Institute of BioMedical Research Corp. engages in research and development, quality control and standardization of pharmaceuticals, cosmetics and food products. The company is headquartered in Niksic, Niksic. The company went IPO on 2000-10-27. The firm's services include scientific research and biomedical services, such as research and development, quality control, standardization of pharmaceuticals, cosmetics and food products. The firm also provides long-term biomedical and environmental research projects, develops new diagnostic biomedical technologies and experimental medical treatments. The firm's products include Aerosan, MicrobEX, Microbicidal Towels KleNET, OralNet, Oral Ocean Power and Purilair. The company offers electro medical devices, such as BioMed 2000 XT with Timer, BioStim INF, QuadStar Elite, QuadStar II, Pain Gone piezo-electric pain relief and Portable Ultra Sound Device. The company offers various services, including quality control services, regulatory services, healthcare services, environmental analyses, building decontamination, and environmental protection and management.
Institute of Biomedical Research Corpの主要な財務諸表は何ですか?
最新の財務諸表(Form-10K)によると、Leishen Energy Holding Co Ltdの総資産は$0で、純損失は$0です。
MRESの主要な財務比率は何ですか?
Leishen Energy Holding Co Ltdの流動比率は0、純利益率は0、1株当たり売上高は$0です。
Institute of Biomedical Research Corpの収益はセグメントまたは地域別にどのように分けられていますか?
Leishen Energy Holding Co Ltd の最大収益セグメントは Clean-energy Equipment で、最新の利益発表における収益は 22,073,207 です。地域別に見ると、China が Leishen Energy Holding Co Ltd の主要市場であり、収益は 48,335,553 です。
Institute of Biomedical Research Corpは収益を上げていますか?
いいえ、最新の財務諸表によると、Leishen Energy Holding Co Ltdの純損失は$0です。
Institute of Biomedical Research Corpに負債はありますか?
いいえ、Leishen Energy Holding Co Ltdの負債は0です。
Institute of Biomedical Research Corpの発行済株式数は何株ですか?